Compare DexCom, Inc. (DXCM) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Wells Fargo & Co — how do they compare? DexCom, Inc. trades at $89.53 (market cap $33.08B), while Wells Fargo & Co trades at $87.31 (market cap $264.66B). The key difference: Wells Fargo & Co is far larger — about 8× DexCom, Inc.'s market cap, and Wells Fargo & Co pays a 2.29% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | WFC | |
|---|---|---|
Market Cap | $33.08B | $264.66B |
Sector | Health | Financials |
52-Week High | $89.53 | $96.40 |
52-Week Low | $54.84 | $73.42 |
Enterprise Value | $32.53B | — |
Dividend Yield | — | 2.29% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
